Bombay HC Dismisses Plea Against ART Age Cap

A significant decision was made by the Bombay High Court on Thursday, as it disposed of a plea challenging the upper age limit for assisted reproductive treatment under the Assisted Reproductive Technology (ART) Act, 2021. The challenge was mounted by two women, aged 54 and 56, who sought to undergo IVF treatment despite being above the age limit of 50 years prescribed by the Act.

The women had filed petitions seeking a declaration that Section 21(g) of the ART Act was unconstitutional and violative of their fundamental rights. They argued that the law created an imbalance by permitting male sperm donors to donate up to the age of 55, while restricting women recipients to 50 years. The petitioners' advocate, Kalyani Tulankar, presented their case, relying on certificates issued by a gynaecologist stating that they were fit to carry pregnancies to full term.

However, the court directed the women to undergo detailed medical tests to assess their physical fitness for IVF. The tests were conducted at Mumbai's government-run Cama and Albless Hospital, and the reports concluded that both women were medically unfit for the procedure. One petitioner was found to be suffering from hypothyroidism for 15 years and had been post-menopausal for two years, while the second petitioner had diabetes mellitus for four years and had been post-menopausal for five years.

The medical reports proved decisive in the court's decision, as they stated that both women were medically unfit to undergo IVF. The court observed that the petitioners had approached the court with the hope of being found medically fit, but since they were found unfit, there was no reason to deal with the challenge to Section 21(g) of the ART Act.

The Assisted Reproductive Technology Act, 2021, regulates assisted reproductive technology services in India, including IVF treatment. The Act prescribes an upper age limit of 50 years for women seeking IVF treatment using donor gametes. The petitioners' challenge to this age limit was seen as a significant test of the Act's constitutionality.

The Bombay High Court's decision highlights the importance of medical fitness in determining eligibility for IVF treatment. The court's ruling also underscores the need for a balanced approach to reproductive rights, taking into account both the rights of individuals and the medical risks associated with IVF treatment.

In recent years, there have been several challenges to the ART Act, with many arguing that the age limit is arbitrary and discriminatory. However, the court's decision in this case suggests that the medical risks associated with IVF treatment at an advanced age cannot be ignored.

The decision is also significant in the context of reproductive rights in India. The country has seen a growing demand for IVF treatment in recent years, driven by factors such as delayed marriage and childbirth. The ART Act aims to regulate this industry and ensure that IVF treatment is provided in a safe and ethical manner.

In conclusion, the Bombay High Court's decision to dismiss the plea against the ART age cap highlights the importance of medical fitness and the need for a balanced approach to reproductive rights. The decision is likely to have significant implications for the regulation of IVF treatment in India and the rights of individuals seeking reproductive services.

The court's ruling also raises important questions about the intersection of law, medicine, and reproductive rights. As the demand for IVF treatment continues to grow, it is likely that there will be further challenges to the ART Act and its provisions. The Bombay High Court's decision provides a significant precedent in this area, emphasizing the need for a nuanced and balanced approach to reproductive rights.

The petitioners have been permitted to obtain copies of the medical reports, and it is likely that they will seek further medical evaluation and advice. The decision is a significant setback for the petitioners, who had hoped to undergo IVF treatment despite being above the age limit.

In the end, the Bombay High Court's decision highlights the complexities and challenges associated with reproductive rights in India. The decision is a significant contribution to the ongoing debate about the regulation of IVF treatment and the rights of individuals seeking reproductive services.

The case has also sparked a wider debate about the role of law in regulating reproductive services. The ART Act is seen as a significant step forward in regulating the IVF industry, but there are still many challenges and complexities that need to be addressed. The Bombay High Court's decision provides a significant insight into the complexities of reproductive rights and the need for a balanced approach to regulation.

The decision is likely to have significant implications for the IVF industry in India, and it is likely that there will be further challenges to the ART Act and its provisions. The Bombay High Court's decision provides a significant precedent in this area, emphasizing the need for a nuanced and balanced approach to reproductive rights.

What it means for Mumbai and India is that the regulation of IVF treatment will continue to be a significant issue, with ongoing debates about the age limit and the rights of individuals seeking reproductive services. The Bombay High Court's decision provides a significant contribution to this debate, highlighting the importance of medical fitness and the need for a balanced approach to reproductive rights.